{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:39:11Z","timestamp":1793709551381,"version":"4.6.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Science and Technology Program Project in the Health Sector of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijid.2026.109196","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:14:34Z","timestamp":1792451674000},"page":"109196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Humoral immune responses following inactivated COVID-19 vaccine with different booster intervals: a randomized interventional immunogenicity study"],"prefix":"10.1016","volume":"173","author":[{"given":"Xinyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijing","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huakun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7334-2536","authenticated-orcid":false,"given":"Hangjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijid.2026.109196_bib0001","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ijid.2026.109196_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.17402","article-title":"Estimated 2023-2024 COVID-19 vaccine effectiveness in adults","volume":"8","author":"Link-Gelles","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijid.2026.109196_bib0003","article-title":"Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis","volume":"37","author":"Law","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"10.1016\/j.ijid.2026.109196_bib0004","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12961-022-00947-7","article-title":"The whole-of-society approach of mass COVID-19 vaccination in China: a qualitative study","volume":"20","author":"Wang","year":"2022","journal-title":"Health Res Policy Syst"},{"issue":"19","key":"10.1016\/j.ijid.2026.109196_bib0005","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"issue":"10309","key":"10.1016\/j.ijid.2026.109196_bib0006","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(21)02183-8","article-title":"Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study","volume":"398","author":"Tartof","year":"2021","journal-title":"Lancet"},{"issue":"7898","key":"10.1016\/j.ijid.2026.109196_bib0007","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 omicron to antibody neutralization","volume":"602","author":"Planas","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ijid.2026.109196_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10050794","article-title":"The SARS-CoV-2 variant omicron is able to escape vaccine-induced humoral immune responses, but is counteracted by booster vaccination","volume":"10","author":"Hastert","year":"2022","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.ijid.2026.109196_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12020144","article-title":"Immune evasion of SARS-CoV-2 omicron subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a cohort of older adults after ChAdOx1-S vaccination and BA.4\/5 bivalent booster","volume":"12","author":"Machado","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2026.109196_bib0010","article-title":"Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): a cross-sectional and cohort study in Zhejiang, China","volume":"12","author":"Zhang","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.ijid.2026.109196_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.939311","article-title":"Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 vaccine: a 6-month population-based cohort study","volume":"13","author":"Hua","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ijid.2026.109196_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13070670","article-title":"COVID-19 vaccine timing and Co-administration with Influenza vaccines in Canada: a systematic review with comparative insights from G7 countries","volume":"13","author":"Al Hashimi","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.ijid.2026.109196_bib0013","article-title":"Immune memory reactivation and T cell dynamics following 12-month homologous CoronaVac booster: a longitudinal cohort study","volume":"16","author":"Song","year":"2025","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.ijid.2026.109196_bib0014","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15585\/mmwr.mm7106a4","article-title":"Genomic surveillance for SARS-CoV-2 variants: predominance of the delta (B.1.617.2) and omicron (B.1.1.529) variants - United States, June 2021-January 2022","volume":"71","author":"Lambrou","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10377","key":"10.1016\/j.ijid.2026.109196_bib0015","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(23)00129-0","article-title":"Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis","volume":"401","author":"Pan","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijid.2026.109196_bib0016","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/14760584.2024.2320861","article-title":"Effect of homologous or heterologous vaccine booster over two initial doses of inactivated COVID-19 vaccine","volume":"23","author":"Luvira","year":"2024","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.ijid.2026.109196_bib0017","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1473-3099(21)00681-2","article-title":"Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials","volume":"22","author":"Zeng","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2026.109196_bib0018","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0264-410X(01)00328-0","article-title":"Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes","volume":"20","author":"Nanan","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ijid.2026.109196_bib0019","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41421-022-00480-5","article-title":"Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profiling","volume":"8","author":"Ai","year":"2022","journal-title":"Cell Discov"},{"issue":"1","key":"10.1016\/j.ijid.2026.109196_bib0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16097-3","article-title":"Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants","volume":"12","author":"Vadrevu","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ijid.2026.109196_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23892","article-title":"Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4\/5 variants at 3\u20134 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination","volume":"10","author":"Assawakosri","year":"2024","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.ijid.2026.109196_bib0022","doi-asserted-by":"crossref","first-page":"125","DOI":"10.46234\/ccdcw2023.023","article-title":"Immunogenicity and safety of homologous booster doses of CoronaVac COVID-19 vaccine in elderly individuals aged 60 years and older: a dosing interval study - Yunnan Province, China, 2021-2022","volume":"5","author":"Yang","year":"2023","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.ijid.2026.109196_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106092","article-title":"Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipients","volume":"235","author":"Wu","year":"2025","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.ijid.2026.109196_bib0024","article-title":"Comparable immune escape capacity between KP.2 and other SARS-CoV-2 variants in the central Chinese population after the first COVID-19 booster","volume":"15","author":"Yuan","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijid.2026.109196_bib0025","article-title":"Domain-specific impacts of spike protein mutations on infectivity and antibody escape in SARS-CoV-2 omicron BA.1","volume":"35","author":"Kim","year":"2025","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.ijid.2026.109196_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2025.112345","article-title":"Antibody escape of SARS-CoV-2 variants of concern on receptor-binding domain: a computational approach","volume":"619","author":"Nguyen","year":"2026","journal-title":"J Theor Biol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226008313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226008313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:21:37Z","timestamp":1793708497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226008313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":26,"alternative-id":["S1201971226008313"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109196","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humoral immune responses following inactivated COVID-19 vaccine with different booster intervals: a randomized interventional immunogenicity study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109196","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"109196"}}